Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Moreau

Showing results (101-110 of 208) with videos related to

Pageof 21
Sort By:
Revue Neurologique|February 25, 2023
A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort studyL Gauer, K Bigaut, É Berger, et al.
Diabetes & Metabolism|August 12, 2003
An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patientsI Girod, P Valensi, C Laforêt, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
The peculiar T-kininase activity of rat mast cell chymaseF Gauthier, T Moreau, N Gutman, et al.
The Biochemical Journal|May 16, 1998
Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venomM Brillard-Bourdet, V Nguyên, M Ferrer-di Martino, et al.
FEBS Letters|September 14, 1992
Inhibition of rat tissue kallikrein gene family members by rat kallikrein-binding protein and alpha 1-proteinase inhibitorC Serveau, T Moreau, G X Zhou, et al.
Revue Neurologique|May 26, 1999
[Multiple sclerosis and pregnancy: clinical issues]C Confavreux, M Hutchinson, M Hours, et al.
Neuroepidemiology|August 22, 2008
Clinical parameters to predict response to interferon in relapsing multiple sclerosisA Fromont, M Debouverie, G Le Teuff, et al.
Cytokine|December 26, 2008
Inflammatory demyelinating events following treatment with anti-tumor necrosis factorA Fromont, J De Seze, M C Fleury, et al.
Revue Neurologique|April 15, 2008
[Alexithymia and links with depression and anxiety in multiple sclerosis]K Chahraoui, J-M Pinoit, N Viegas, et al.
European Neurology|April 15, 1999
Simultaneous medullar and cutaneous revelation of a cutaneomeningospinal angiomatosisP Krolak-Salmon, T Moreau, F Bouhour, et al.
Pageof 21

Showing results (101-110 of 208) with videos related to

Sort By:
Pageof 21
Revue Neurologique|February 25, 2023
A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort studyL Gauer, K Bigaut, É Berger, et al.
Diabetes & Metabolism|August 12, 2003
An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patientsI Girod, P Valensi, C Laforêt, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
The peculiar T-kininase activity of rat mast cell chymaseF Gauthier, T Moreau, N Gutman, et al.
The Biochemical Journal|May 16, 1998
Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venomM Brillard-Bourdet, V Nguyên, M Ferrer-di Martino, et al.
FEBS Letters|September 14, 1992
Inhibition of rat tissue kallikrein gene family members by rat kallikrein-binding protein and alpha 1-proteinase inhibitorC Serveau, T Moreau, G X Zhou, et al.
Revue Neurologique|May 26, 1999
[Multiple sclerosis and pregnancy: clinical issues]C Confavreux, M Hutchinson, M Hours, et al.
Neuroepidemiology|August 22, 2008
Clinical parameters to predict response to interferon in relapsing multiple sclerosisA Fromont, M Debouverie, G Le Teuff, et al.
Cytokine|December 26, 2008
Inflammatory demyelinating events following treatment with anti-tumor necrosis factorA Fromont, J De Seze, M C Fleury, et al.
Revue Neurologique|April 15, 2008
[Alexithymia and links with depression and anxiety in multiple sclerosis]K Chahraoui, J-M Pinoit, N Viegas, et al.
European Neurology|April 15, 1999
Simultaneous medullar and cutaneous revelation of a cutaneomeningospinal angiomatosisP Krolak-Salmon, T Moreau, F Bouhour, et al.
Pageof 21